Clinical Director, Hepatology
Department / Division:
Medicine
/
Gastroenterology
Address:
DUMC 3913
Durham, NC 27710
Appointment Telephone:
919-684-6437
Office Telephone:
919-684-2052
Fax Telephone:
919-684-8264
Clinical Interests:
General and transplant hepatology
Research Interests:
· Hepatitis C
· Liver Transplantation
· Hepatocellular carcinoma
· Clinical Trials
· Racial disparities in liver disease
· Outcomes Research
Representative Publications:
Lawitz E, Rodriguez-Torres M, Muir AJ, Kieffer TL, McNair L, Khunvichai A, McHutchison JG. Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients. J Hepatol. 2008 Aug;49(2):163-9.
(2008)
Abstract
Jou JH, Muir AJ. In the clinic. Hepatitis C. Ann Intern Med. 2008 Jun 3;148(11):ITC6-1-ITC6-16.
(2008)
Abstract
Brady CW, Smith AD, Stechuchak KM, Coffman CJ, Tuttle-Newhall JE, Provenzale D, Muir AJ. Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era. Liver Transpl. 2008 Feb;14(2):228-34.
(2008)
Abstract
Ramamurthy M, Muir AJ. Treatment of hepatitis C in special populations. Clin Liver Dis. 2006 Nov;10(4):851-65.
(2006)
Abstract
Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ. 2006 Apr 29;332(7548):1013-7.
(2006)
Abstract
Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation. 2005 Jul 15;80(1):145-8.
(2005)
Abstract
Muir AJ, Bornstein JD, Killenberg PG, . Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med. 2004 May 27;350(22):2265-71.
(2004)
Abstract